Lichtenstein Chen 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Dec 4, 2025
Insider Transaction Report
Form 4
Lichtenstein Chen
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-12-02+4,804→ 4,804 total - Exercise/Conversion
Restricted Share Units
2025-12-02−4,804→ 0 total→ Ordinary Shares (4,804 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on December 2, 2024 and vested on December 2, 2025.